SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-213390
Filing Date
2017-06-26
Accepted
2017-06-26 17:01:02
Documents
3
Effectiveness Date
2017-06-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d414000ddefa14a.htm DEFA14A 22343
2 GRAPHIC g414000img2.jpg GRAPHIC 9274
3 GRAPHIC g414000nnimx1.jpg GRAPHIC 9865
  Complete submission text file 0001193125-17-213390.txt   50115
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 17930440
SIC: 2834 Pharmaceutical Preparations